Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Deborah Collyar: What's In It for Patients?

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Jan
21
Today In Oncology
Meningiomas: Phase II Trial Shows Activity of Targeted Therapy
IMPT vs IMRT in Oropharyngeal Cancer
Investigational Vaccine Intercepts Cancer Cells in Lynch Syndrome Carriers
Regulatory Agencies Establish Principles of Good AI Use in Drug Development
Genetic Predisposition to Higher Body Mass Index Linked to Mortality After Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo